TITLE

Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions

AUTHOR(S)
Juan Wang; Jie Hao; Donghui Bai; Qi Gu; Weifang Han; Lei Wang; Yuanqing Tan; Xia Li; Ke Xue; Pencheng Han; Zhengxin Liu; Yundan Jia; Jun Wu; Lei Liu; Liu Wang; Wei Li; Zhonghua Liu; Qi Zhou
PUB. DATE
November 2015
SOURCE
Stem Cell Research & Therapy;11/12/2015, Vol. 6, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: Human induced pluripotent stem cells (hiPSCs) are considered as one of the most promising seed cell sources in regenerative medicine. Now hiPSC-based clinical trials are underway. To ensure clinical safety, cells used in clinical trials or therapies should be generated under GMP conditions, and with Xeno-free culture media to avoid possible side effects like immune rejection that induced by the Xeno reagents. However, up to now there are no reports for hiPSC lines developed completely under GMP conditions using Xeno-free reagents. Methods: Clinical-grade human foreskin fibroblast (HFF) cells used as feeder cells and parental cells of the clinical-grade hiPSCs were isolated from human foreskin tissues and cultured in Xeno-free media. Clinical-grade hiPSCs were derived by integration-free Sendai virus-based reprogramming kit in Xeno-free pluritonâ„¢ reprogramming medium or X medium. Neural cells and cardiomyocytes differentiation were conducted following a series of spatial and temporal specific signals induction according to the corresponding lineage development signals. Biological safety evaluation of the clinical-grade HFF cells and hiPSCs were conducted following the guidance of the "Pharmacopoeia of the People's Republic of China, Edition 2010, Volume III". Results: We have successfully derived several integration-free clinical-grade hiPSC lines under GMP-controlled conditions and with Xeno-free reagents culture media in line with the current guidance of international and national evaluation criteria. As for the source of hiPSCs and feeder cells, biological safety evaluation of the HFF cells have been strictly reviewed by the National Institutes for Food and Drug Control (NIFDC). The hiPSC lines are pluripotent and have passed the safety evaluation. Moreover, one of the randomly selected hiPSC lines was capable of differentiating into functional neural cells and cardiomyocytes in Xeno-free culture media. Conclusion: The clinical-grade hiPSC lines therefore could be valuable sources for future hiPSC-based clinical trials or therapies and for drug screening.
ACCESSION #
110970355

 

Related Articles

  • Analysis of Embryoid Bodies Derived from Human Induced Pluripotent Stem Cells as a Means to Assess Pluripotency. Sheridan, Steven D.; Surampudi, Vasudha; Rao, Raj R. // Stem Cells International;2012, p1 

    Human induced pluripotent stem cells (hiPSCs) have core properties of unlimited self-renewal and differentiation potential and have emerged as exciting cell sources for applications in regenerative medicine, drug discovery, understanding of development, and disease etiology. Key among numerous...

  • Fibroblast-like cells as an effective feeder for the cultivation and derivation of new lines of human induced pluripotent stem cells. Novosadova, E.; Manuilova, E.; Arsenyeva, E.; Grivennikov, I.; Myasoedov, N. // Doklady Biochemistry & Biophysics;Sep2016, Vol. 470 Issue 1, p353 

    Induced pluripotent stem cells (iPSCs) can be a highly informative model of hereditary and sporadic human diseases. In the future, such cells can be used in substitution and regenerative therapy of a wide range of diseases and for the treatment of injuries and burns. The ability of iPSCs derived...

  • Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications. Liu, Gele; David, Brian T.; Trawczynski, Matthew; Fessler, Richard G. // Stem Cell Reviews & Reports;Feb2020, Vol. 16 Issue 1, p3 

    Over the past 20 years, and particularly in the last decade, significant developmental milestones have driven basic, translational, and clinical advances in the field of stem cell and regenerative medicine. In this article, we provide a systemic overview of the major recent discoveries in this...

  • Nonhuman Primate Induced Pluripotent Stem Cells in Regenerative Medicine. Yuehong Wu; Mishra, Anuja; Qiu, Zhifang; Farnsworth, Steven; Tardif, Suzette D.; Hornsby, Peter J. // Stem Cells International;2012, p1 

    Among the various species from which induced pluripotent stem cells have been derived, nonhuman primates (NHPs) have a unique role as preclinical models. Their relatedness to humans and similar physiology, including central nervous system, make them ideal for translational studies. We review...

  • Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Lee, Andrew S; Tang, Chad; Rao, Mahendra S; Weissman, Irving L; Wu, Joseph C // Nature Medicine;Aug2013, Vol. 19 Issue 8, p998 

    Human pluripotent stem cells (PSCs) are a leading candidate for cell-based therapies because of their capacity for unlimited self renewal and pluripotent differentiation. These advances have recently culminated in the first-in-human PSC clinical trials by Geron, Advanced Cell Technology and the...

  • Development of humanized culture medium with plant-derived serum replacement for human pluripotent stern cells. Kunova, Michaela; Matulka, Kamil; Eiselleova, Livia; Trckova, Petra; Hampl, Ales; Dvorak, Petr // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2010, Vol. 21 Issue 5, p676 

    For human embryonic stem cells (ESC) to be used in cell replacement therapies, they must be grown under good manufacturing conditions in a chemically defined medium that lacks animal proteins. This study examined the ability of a newly designed medium containing the plant-derived serum...

  • Small Molecule-Assisted, Line-Independent Maintenance of Human Pluripotent Stem Cells in Defined Conditions. Frank, Stefan; Zhang, Miao; Schöler, Hans R.; Greber, Boris // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    Human pluripotent stem cells (hPSCs) are conventionally grown in a mouse feeder cell-dependent manner. Chemically defined culture conditions are, however, desirable not only for potential medically oriented applications but also for investigating mechanisms of self-renewal and differentiation....

  • Derivation of Transgene-Free Human Induced Pluripotent Stem Cells from Human Peripheral T Cells in Defined Culture Conditions. Kishino, Yoshikazu; Seki, Tomohisa; Fujita, Jun; Yuasa, Shinsuke; Tohyama, Shugo; Kunitomi, Akira; Tabei, Ryota; Nakajima, Kazuaki; Okada, Marina; Hirano, Akinori; Kanazawa, Hideaki; Fukuda, Keiichi // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    Recently, induced pluripotent stem cells (iPSCs) were established as promising cell sources for revolutionary regenerative therapies. The initial culture system used for iPSC generation needed fetal calf serum in the culture medium and mouse embryonic fibroblast as a feeder layer, both of which...

  • Regenerative Medicine: On the Vanguard of Health Care. Terzic, Andre; Folmes, Clifford D.; Martinez-Fernandez, Almudena; Behiar, Atta // Mayo Clinic Proceedings;Jul2011, Vol. 86 Issue 7, p600 

    An introduction is presented in which the editors discuss regenerative medicine which highlights the science and ethics of induced pluripotency.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics